Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
about
Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsEffect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients.Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis.
P2860
Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
@en
type
label
Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
@en
prefLabel
Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
@en
P2860
P356
P1476
Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.
@en
P2093
Adnan AbuHammour
Asad Dajani
P2860
P304
P356
10.4103/1319-3767.178527
P5008
P577
2016-03-01T00:00:00Z